À proposConditionsConfidentialitéContact
 
Actualisation
VJHemOnc Podcast

VJHemOnc Podcast

Date de sortie : 2026-01-09
© Copyright 2020 All rights reserved.
VJHemOnc Podcast - QR Code
200 épisodes
Audio
Écouter sur Apple Podcasts
200 épisodes
Audio
Écouter sur Apple Podcasts
Date de sortie : 2026-01-09
© Copyright 2020 All rights reserved.
L’épisode le plus récent
Top updates in myeloma from ASH 2025: the RedirecTT-1 and MajesTEC-3 trials, dual-targeting CAR-T, trispecific antibodies, and more!

Top updates in myeloma from ASH 2025: the RedirecTT-1 and MajesTEC-3 trials, dual-targeting CAR-T, trispecific antibodies, and more!

This podcast features key updates in multiple myeloma from ASH 2025. Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, discusses redefining functional high-risk myeloma in the era of upfront quadruplet therapy and autologous stem cell tran
Durée : 32:01
This podcast features key updates in multiple myeloma from ASH 2025. Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, discusses redefining functional high-risk myeloma, followed by Nisha Joseph, MD, Winship Cancer Institute, Emory University, Atlanta, GA, who shares results from a Phase II dose-optimization study (NCT04068597) of inobrodib with pomalidomide and dexamethasone.
Updates on CAR T-cell therapies are given by Shambavi Richard, MD, Mount Sinai, New York City, NY, Krina Patel, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, and Samir Parekh, MD, Icahn School of Medicine at Mount Sinai, New York City, NY.
Finally, Salomon Manier, MD, PhD, Lille Hospital University, Lille, France, Dickran Kazandjian, MD, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, Shahzad Raza, MD, Cleveland Clinic, Cleveland, OH, Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, and Amrita Krishnan, MD, City of Hope, Duarte, CA, discuss T-cell engaging antibodies.
Id. d’épisode : 1000744453961
GUID : vjhemonc.podbean.com/6df23cf4-1199-3779-87c6-5e409fae2eae
Date de publication : 9/1/2026 à 16:12:40

Description

The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

Apple Podcasts : Avis des utilisateurs

Pas d'entrée